3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polycystic Ovary Syndrome
9
Motor Activity
7
Prostatic Neoplasms
3
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lupus Erythematosus, Systemic
1
Insulin Resistance
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Diabetes Mellitus, Type 1
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Arthritis, Rheumatoid
1
Anxiety Disorders
1
Interventions
Sorafenib
121
Nivolumab
36
pembrolizumab
32
Bevacizumab
28
lenvatinib
27
Doxorubicin
23
Radiosurgery
21
Radiofrequency Ablation
20
Oxaliplatin
20
Hepatectomy
18
Fluorouracil
15
Capecitabine
15
Magnetic Resonance Spectroscopy
14
atezolizumab
13
Leucovorin
13
Cisplatin
13
Gemcitabine
11
Erlotinib Hydrochloride
11
tislelizumab
9
Sirolimus
9
Radiotherapy
9
Irinotecan
9
Ipilimumab
9
cabozantinib
8
Liver Transplantation
8
regorafenib
7
Ramucirumab
7
Folfox protocol
7
Embolization, Therapeutic
7
sintilimab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Hepatocellular
×
High-Intensity Interval Training
×
Clear all
NCT03518632
2022-07-19
APACHE
Centre Hospitalier Universitaire de Besancon
Phase NA
Completed
8 enrolled